{"version":"1.0","type":"link","title":"Molecular and Immune Correlates of Response to First-Line De-escalated Chemotherapy plus Penpulimab and Anlotinib in Advanced Cervical Cancer.","author_name":"Xu Q 외","author_url":"https://prs-insight.online/author/Xu%20Q","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/167870","thumbnail_width":1200,"thumbnail_height":630}